Scientific Sessions 2024  /  Hot Debates in Heart Failure  /  CRISPR Clarity: The Time is Now for Gene Editing in Cardiomyopathy
Logo

American Heart Association

  105
  0

Final ID:

CRISPR Clarity: The Time is Now for Gene Editing in Cardiomyopathy

  • Musunuru, Kiran  ( Perelman School of Medicine , Philadelphia , Pennsylvania , United States )
  • Olson, Eric  ( UNIV TEXAS SOUTHWESTERN MED CTR , Dallas , Texas , United States )
    • Author Disclosures:
    Kiran Musunuru: DO have relevant financial relationships ; Advisor:Verve Therapeutics:Active (exists now) ; Advisor:Capstan Therapeutics:Active (exists now) ; Advisor:LEXEO Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Beam Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Nava Therapeutics:Active (exists now) ; Ownership Interest:Variant Bio:Active (exists now) ; Individual Stocks/Stock Options:Verve Therapeutics:Active (exists now) | Eric Olson: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Hot Debates in Heart Failure

Monday, 11/18/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
CRISPR Quagmire: Weighing the Risks of Gene Therapies

Mammen Pradeep, Alexander Kevin

CON: Lightening the Load: Use of GLP-1 Receptor Agonists in Heart Failure

Nazha Hamdani, Butler Javed

More abstracts from these authors:
Transcriptional Condensates Regulate Smooth Muscle Cell Phenotypic Switching

Gan Peiheng, Liu Ning, Olson Eric

Immune Targets in Cardiac Regeneration

Rosenthal Nadia, Olson Eric

You have to be authorized to contact abstract author. Please, Login
Not Available